The neonatal Fc receptor (FcRn) is not required for IVIg or anti-CD44 monoclonal antibody-mediated amelioration of murine immune thrombocytopenia.
about
Targeting the Fc receptor in autoimmune diseaseImmune recruitment or suppression by glycan engineering of endogenous and therapeutic antibodiesImmunoglobulin G dimers and immune complexes are dispensable for the therapeutic efficacy of intravenous immune globulin in murine immune thrombocytopenia.Cellular immune dysfunction in immune thrombocytopenia (ITP).Amelioration of murine passive immune thrombocytopenia by IVIg and a therapeutic monoclonal CD44 antibody does not require the Myd88 signaling pathway.CD44 antibody-mediated amelioration of murine immune thrombocytopenia (ITP): mouse background determines the effect of FcγRIIb genetic disruption.Fully human monoclonal antibody inhibitors of the neonatal fc receptor reduce circulating IgG in non-human primates.Review: intravenous immunoglobulin and B cells: when the product regulates the producer.IVIG-mediated effector functions in autoimmune and inflammatory diseases.Therapeutic effect of IVIG on inflammatory arthritis in mice is dependent on the Fc portion and independent of sialylation or basophils.Therapeutic Potential of Intravenous Immunoglobulin in Acute Brain Injury.Massive immune response against IVIg interferes with response against other antigens in mice: A new mode of action?Structural basis for pH-insensitive inhibition of immunoglobulin G recycling by an anti-neonatal Fc receptor antibody.Antibody specific for the glycophorin A complex mediates intravenous immune globulin-resistant anemia in a murine model.
P2860
Q27002843-BF164898-1F3F-4CC6-B719-F53116D7604FQ28069362-307C4B46-5A5A-40BF-8FF4-1F24B2519E44Q33401630-78B3B826-71A0-419B-AF69-790611F6328BQ33409710-15BAFB48-7EE5-4A25-9051-7F4670459009Q33409741-BCECF267-F839-4975-8560-1E5E7C40C3C6Q33419269-A597F51B-0220-4A3A-BF6F-84444808CE27Q35531873-A3F45881-E7B7-40DD-AA4D-B982EAFB08A2Q38258905-39FB34B8-BFE4-48E9-AB13-A2EB93A07CE0Q38699812-5F8A9CEC-67B8-4CB7-AA42-8FB373E4359CQ39729881-79196DAB-CDF6-4F2E-9D93-372DF47BBE27Q41170285-5780ECC9-42DB-40F9-B800-0C19443911F6Q42375731-8E7B77EA-932D-403A-9B53-FCAEA5572266Q47846522-C0AB3AC2-FE94-4E09-B619-03F841795DB2Q50894879-56C39A7F-4F5A-44DB-8AA4-1EA8E5D044C3
P2860
The neonatal Fc receptor (FcRn) is not required for IVIg or anti-CD44 monoclonal antibody-mediated amelioration of murine immune thrombocytopenia.
description
2011 nî lūn-bûn
@nan
2011 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
The neonatal Fc receptor (FcRn ...... urine immune thrombocytopenia.
@ast
The neonatal Fc receptor (FcRn ...... urine immune thrombocytopenia.
@en
type
label
The neonatal Fc receptor (FcRn ...... urine immune thrombocytopenia.
@ast
The neonatal Fc receptor (FcRn ...... urine immune thrombocytopenia.
@en
prefLabel
The neonatal Fc receptor (FcRn ...... urine immune thrombocytopenia.
@ast
The neonatal Fc receptor (FcRn ...... urine immune thrombocytopenia.
@en
P2093
P1433
P1476
The neonatal Fc receptor (FcRn ...... urine immune thrombocytopenia.
@en
P2093
Patrick J Mott
Sara J Suppa
P304
P356
10.1182/BLOOD-2011-08-374223
P407
P577
2011-10-14T00:00:00Z